Uncategorized

There is growing investment in fighting bacterial growth in a wide range of settings, with the market estimated to reach more than $3 billion within eight years.

Stringent regulation, manufacturing costs and absence of price control contribute to high GLP-1 agonist costs in the U.S. Patients could go to other countries for cheaper treatment.

The collaboration comes after Agilent restructured and sold its liquid biopsy unit. 

HCA executives also announced the retirement of longtime CFO Bill Rutherford during a Tuesday earnings call.

However, growth in Medicare’s flagship shared savings model has plateaued over the past five years, according to government data.

Insurers’ MA earnings were 2% lower in 2022 than in 2019, signaling profits in the lucrative insurance program may be weakening.

Effective March 18, Nakesha Lopez will lead human resource and people programs for the 68-hospital nonprofit.

Gaeta is filling the vacancy created by Dan Puckett, who retired from the position this week.

The sector’s recovery has been slower than expected since the COVID-19 pandemic. In a new report, the credit agency said some hospitals may never reach traditional healthy operating margins. 

Medtronic, Boston Scientific and J&J are among the medtech companies advancing treatments in cardiac care for when medicines are not enough.